Australia's best-known stem cell scientist has asked that researchers hold off lobbying for therapeutic cloning in order to cement the concessions granted by the Prime Minister so far. [ + ]

Australian biological researchers aren't responding in hoped-for numbers to offers of access at bargain basement rates to US company Celera Genomics' genome databases. [ + ]

Industry organisation AusBiotech is to set up a working group to deliver the recommendations of a pre-clinical development meeting held in Melbourne this week. [ + ]

Researchers at CSIRO Plant Industry have used the publicly available rice genome sequence to isolate the semi-dwarfing gene in varieties responsible for the 'green revolution' and develop 'perfect' markers for it. [ + ]

Adelaide-based company BresaGen and British Biotech have ended a collaboration to develop GM-CSF antagonist E21R, after fresh tests failed to confirm previous assessments of its commercial prospects. [ + ]

Enzymes, nature's natural catalysts that speed the chemical reactions of life in all living cells, are already widely used in the food and other industries.

A group based at the University of Technology, Sydney, has developed a unique method of processing coral, which may allow it to be used in orthopaedic implants. [ + ]

Hour-long waits for results from gene and protein database searches that now take a few minutes could become reality within a few years, according to a search engine expert. [ + ]

A greater focus was needed on advancing Australia's pre-clinical development capabilities, a biotechnology conference was told today. [ + ]

Cardia Technologies has signed an option agreement worth $10,000 on diabetes type 1 food toxin research at the International Diabetes Institute (IDI). [ + ]

Small to medium-sized biotechnology companies are missing out on an important source of cash by failing to claim the Federal R&D rebate, according to a tax specialist. [ + ]

One of the commanding figures on Queensland's life science scene, Prof Peter Andrews, is resigning as co-head of the state's flagship biotech research centre, the Institute for Molecular Bioscience. [ + ]

Australian proteomics research will receive a $50 million boost, thanks to a five-year program now being negotiated by three universities, a private company and the Australian Proteome Analysis Facility (APAF). [ + ]

It is often the small things in life that have the greatest effect on our standard of living and the fascinating science of particle technology is certainly no exception. The application of particle technology is as varied and far-reaching as determining the taste of chocolate by the size of the milk and chocolate particles to the processes involved in refining petrol.

Meditech company ResMed's latest sleep apnoea devices, the S7 Elite CPAP and AutoSet Spirit autotitrating devices, have been approved by the FDA for sale in the USA. [ + ]